Clinical Trial Update: Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating AL-59412C in open-angle glaucoma and ocular hypertension reported safety data and intraocular pressure-lowering effects, but the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• AL-59412C

Snippet

Sponsor: Alcon Research | Conditions: Open-angle Glaucoma, Ocular Hypertension | Phase 2 | Status: TERMINATED